Navigation Links
KIT presents innovations at the 2011 Hannover Messe
Date:3/30/2011

of high storage capacity, reliability, and service life. Work comprises the specific synthesis, characterization, and functionalization of nanoscaled materials as well as the setup and application of the corresponding process technology. Early this year, KIT founded the new Ulm Helmholtz Institute Electrochemical Energy Storage in cooperation with Ulm University. Associated partners are the German Aerospace Center (DLR) and the Center for Solar Energy and Hydrogen Research Baden-Wrttemberg (ZSW). In addition, the BELLA (Batteries and Electrochemistry Laboratory) joint laboratory was established recently, in which KIT and BASF SE will jointly develop new battery materials.

Electronics from the printer. Printed electronics is an example of how nanotechnology modifies existing products and opens up future markets. It is based on the production of electronic components by means of standard printing methods, such as inkjet printing, screen printing, offset printing, or gravure printing. Scientists of KIT focus on the synthesis of new printable organic and inorganic materials, on their electronic functionalities, and the formulation and production of printing inks. Other main activities are the manufacture of organic solar cells and light-emitting diodes as well as the development of industrial coating and drying processes. Laboratory findings are transferred to mass production. Organic light-emitting diodes (OLED) and printed solar cells, luminescent nanomaterials, and a roll used for gravure printing will be presented at the stand. Another exhibit will be a printer of foils acting like a transistor.

KIC InnoEnergy. The European Knowledge and Innovation Community (KIC) InnoEnergy is a network of excellent actors enterprises, research institutions, universities, and business schools to more rapidly commercialize new energy technologies and create a sustainable energy system in Europe. The network funded by the European Institute of Innovation and Tec
'/>"/>

Contact: Monika Landgraf
monika.landgraf@kit.edu
49-721-608-47414
Helmholtz Association of German Research Centres
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. 23andMe presents top 10 most interesting genetic findings of 2010
2. Colossal fossil: Museums new whale skeleton represents decades of research
3. UC doctoral student presents research at international conference
4. American Society of Agronomy presents 2010 Fellows
5. AMP presents at FDA meeting on regulating diagnostics
6. AAPS presents therapeutic protein drug interactions workshop
7. ASNTR meeting presents Sanberg Awards to Prof. Lin & Prof. Dunnett
8. Latino Theater Company Presents Dementia Starting April 29
9. Hormone sensitivity of breast stem cells presents drug target
10. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
11. P&G Beauty & Grooming presents advancements in skin care at AAD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
KIT presents innovations at the 2011 Hannover Messe 
(Date:9/16/2014)... Menopause Society (NAMS) has published its key, evidence-based ... everything from hot flashes to heart disease. The ... for Clinical Care of Midlife Women," was published ... . This is the first, comprehensive set of ... freely available to all clinicians who care for ...
(Date:9/16/2014)... Two Johns Hopkins neuroscientists have discovered the "molecular brakes" ... inner ear cochleas of mice. These "hair cells" translate ... the brain and are interpreted as sounds. If the ... , A summary of the research will be ... Sept. 16. , "The proteins Hey1 and Hey2 act ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3
... world,s top biodiversity hotspot for reptiles and amphibians, according ... from the University of California, Berkeley, Southern Illinois University ... The park, which encompasses lowland Amazonian rain forest, high-altitude ... well known for its huge variety of bird life, ...
... to climate change are being compiled by research groups ... various sources results in different climate projections; hence, the ... arrive at a consensus regarding future climate estimates. ... SIAM Journal on Uncertainty Quantification , authors Matthew ...
... , New Rochelle, NY, February 19, 2014Joseph C. Glorioso, ... devoted much of his research career to developing herpes ... cells. In recognition of his leadership and accomplishments, ... Gene Therapy , a peer-reviewed journal from Mary Ann ...
Cached Biology News:Peru's Manu National Park sets new biodiversity record 2Peru's Manu National Park sets new biodiversity record 3Statistics research could build consensus around climate predictions 2Statistics research could build consensus around climate predictions 3Statistics research could build consensus around climate predictions 4Joseph Glorioso, Ph.D., receives Pioneer Award 2
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... 17, 2014 A biodegradable polymer ... such as bacteria, fungi, and algae into smaller ... biomass, inorganic compounds, carbon dioxide, and humus in ... base and improved costs, biodegradable polymers are proving ... alternative to conventional polymers. Primary factors that are ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
Breaking Biology Technology:Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4
... 15, 2011 Generex Biotechnology Corporation ( www.generex.com ... the status of the previously announced spinout of ... ). The Company is in the ... several transaction opportunities, including both shell companies and ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... provide an overview of the company,s business strategy at ... the UBS 2011 Global Life Sciences Conference which will ... addition, Geoffrey Nichol, M.B., Ch.B., Sangamo,s executive vice president ...
... Aperion Biologics, Inc. announced that it has reached ... Company,s clinical trial of its Z-Lig™ Anterior Cruciate Ligament ... of the knee. The randomized multicenter study commenced in ... provide safety and performance data in the reconstruction of ...
Cached Biology Technology:Generex Provides Update on Spinout of Antigen Express 2Generex Provides Update on Spinout of Antigen Express 3Generex Provides Update on Spinout of Antigen Express 4Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference 2Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 2